CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
J Exp Med. 2022 Aug 1;219(8):e20200418. doi: 10.1084/jem.20200418. Epub 2022 Jun 10.
J Exp Med. 2022.
PMID: 35687056
Free PMC article.